Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
NVAX
NOVAVAX INC
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$10.81
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$1.78B
RECENT INSIDER TRADES
2026-04-28
· Newton Charles W.
(Director)
· OTHER
2026-03-12
· Shiver John W.
(Director)
· OTHER
2026-03-09
· Kelly James Patrick
(EVP, CFO and Treasurer)
· OTHER
2026-03-05
· Casey Mark J
(EVP, Chief Legal Officer)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
289
Shares held
145,712,682
Value
$1.36B
Percent of shares outstanding
88.34%
As of quarter end
2026-06-30
RECENT NEWS
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
Novavax: Sell The False Plague Breakout
Novavax: Vaccine Maker Sees Momentum In 2026, But Growth Story Holds Fundamental Risks
Novavax, Moderna cool as WHO downplays plague-related death in Russia
Why is Novavax stock surging today?
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS